Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Elderly Immune System”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT04950452
What this trial is testing

Exercise Training to Promote Resilience to Chronic Lymphocytic Leukemia

Who this might be right for
AgingChronic Lymphocytic Leukemia
Duke University 20
Post-approval studies (Phase 4)Study completedNCT01544114
What this trial is testing

A Safety Study of VIMOVO in Adolescents With Juvenile Idiopathic Arthritis (JIA)

Who this might be right for
Juvenile Idiopathic Arthritis (JIA)
Amgen 46
Post-approval studies (Phase 4)Study completedNCT04276233
What this trial is testing

Efficacy and Safety Study of Mepolizumab 100 Milligram (mg) Subcutaneous (SC) in Indian Participants Aged Greater Than or Equal to (>=) 18 Years With Severe Eosinophilic Asthma

Who this might be right for
Asthma
GlaxoSmithKline 100
Not applicableActive Not RecruitingNCT05937321
What this trial is testing

National Institute of Diabetes and Digestive Kidney Diseases* Share Plus: Continuous Glucose Monitoring With Data Sharing in Older Adults With Type 1 Diabetes* and Their Care Partners to Improve Time in Range and Reduce Diabetes Distress.

Who this might be right for
Diabetes Mellitus, Type 1
University of Utah 168
Testing effectiveness (Phase 2)Study completedNCT01453296
What this trial is testing

Pharmacokinetics and Pharacodynamics of GW642444 in Paedetric Subjects

Who this might be right for
Asthma
GlaxoSmithKline 28
Testing effectiveness (Phase 2)WithdrawnNCT02082405
What this trial is testing

Bortezomib, Dexamethasone, and Cyclophosphamide in Treating Older Patients With Multiple Myeloma

Who this might be right for
Stage I Multiple MyelomaStage II Multiple MyelomaStage III Multiple Myeloma
Case Comprehensive Cancer Center
Testing effectiveness (Phase 2)UnknownNCT00199186
What this trial is testing

Study Comparing Imatinib With Chemotherapy as Induction in Elderly Patients With Philadelphia Positive Acute Lymphoblastic Leukemia (ALL)

Who this might be right for
Philadelphia Positive Acute Lymphoblastic LeukemiaLymphoid Blastic Phase of Chronic Myeloid Leukemia
Johann Wolfgang Goethe University Hospital
Post-approval studies (Phase 4)Study completedNCT00386334
What this trial is testing

A Long-Term Safety and Efficacy Study of Eszopiclone in Elderly With Primary Chronic Insomnia

Who this might be right for
Insomnia
Sumitomo Pharma America, Inc. 388
Testing effectiveness (Phase 2)UnknownNCT01670370
What this trial is testing

Trial of R-GemOx Regimen in Previously Untreated Elderly Patients With DLBCL.

Who this might be right for
Diffuse Large B-cell Lymphoma
The First Affiliated Hospital with Nanjing Medical University 60
Not applicableStudy completedNCT04194840
What this trial is testing

Transplant Wellness Clinic for Elderly or High Risk Patients Undergoing BMT

Who this might be right for
Stem Cell Transplant ComplicationsMyelomaLymphoma+1 more
Case Comprehensive Cancer Center 20
Not applicableStudy completedNCT01959646
What this trial is testing

The Effect of AGE on the Immune System

Who this might be right for
Healthy
University of Florida 91
Large-scale testing (Phase 3)Study completedNCT01730976
What this trial is testing

Asthma in the Elderly: The Role of Vitamin D

Who this might be right for
Asthma in the Elderly
Rohr and Columbo Asthma, Allergy and Immunology Specialists, P.C. 30
Testing effectiveness (Phase 2)Looking for participantsNCT06735248
What this trial is testing

Investigate Multiple Sclerosis Relapse Prevention With mRNA-1195 Compared With Placebo in Participants Aged 18 to ≤55 Years

Who this might be right for
Multiple Sclerosis
ModernaTX, Inc. 180
Not applicableNot Yet RecruitingNCT07153315
What this trial is testing

AI-Based Medical Data Analysis for Differentiating Inflammatory vs Degenerative Joint Diseases in Elderly Patients

Who this might be right for
Arthritis, Rheumatoid (RA)
Assiut University 140
Testing effectiveness (Phase 2)Looking for participantsNCT06791291
What this trial is testing

Efficacy and Safety of Teplizumab in Japanese Participants With Stage 2 Type 1 Diabetes

Who this might be right for
Type 1 Diabetes Mellitus
Sanofi 10
Not applicableLooking for participantsNCT05947136
What this trial is testing

PASCA-MM Study. Impact of the PASCA (PArcours de Santé au Cours du CAncer) Program on Complications Associated With Multiple Myeloma and/or Its Treatments in the Context of a First Hematopoietic Stem Cell Autograft, in Adults Aged 18 to 70.

Who this might be right for
Multiple MyelomaComplication
Centre Leon Berard 204
Testing effectiveness (Phase 2)Study completedNCT02741128
What this trial is testing

Safety and Immunogenicity of a Tetravalent Dengue Vaccine in HIV-Positive Adults

Who this might be right for
Dengue FeverDengue Hemorrhagic FeverHuman Immunodeficiency Virus
Sanofi Pasteur, a Sanofi Company 133
Post-approval studies (Phase 4)Study completedNCT01225991
What this trial is testing

Milnacipran for Treatment of Pain in Older Adults With Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
University of California, Los Angeles 18
Not applicableStudy completedNCT04030520
What this trial is testing

Improving Uptake and Adherence to HIV Prevention Services With Pre-exposure Prophylaxis (PrEP), HIV Self- Testing and Adherence Support for Very High Risk HIV-negative Young Women Aged 15-24 in Kampala, Uganda

Who this might be right for
HIV/AIDS
University of California, San Francisco 60
Large-scale testing (Phase 3)Looking for participantsNCT06807281
What this trial is testing

A Long-term Study of the Medicine Called Abrocitinib in Children Aged 2 Years and Older With Moderate to Severe Eczema

Who this might be right for
Atopic Dermatitis
Pfizer 500
Next Page